Literature DB >> 978227

Neurochemical findings in a perinatal sudanophilic leukodystrophy rich in steryl ester.

R B Ramsey, N L Banik, P T Ramsey, M L Cuzner, T Scott, A D Dayan, A N Davison.   

Abstract

Neurochemical and neuropathological studies have been made of a 10-day-old child who suffered from a sudanophilic leukodystrophy. The brain white matter contained abundant sudanophilic material. The patient's grey matter total cholesterol content was 30% higher than whole brain tissue derived from a comparable control. White matter cholesterol content was more than double the control value. Nearly 80% of the white matter cholesterol was esterified. Subcellular fractionation of the white matter resulted in a "floating fraction" rich in cholesteryl ester. The steryl ester fatty acid composition was not typical of control tissue or demyelinating tissue. Patient phospholipid fatty acid composition patterns differed from control, but white matter galactolipid fatty acid composition appeared normal. Cholesteryl ester hydrolase activity appeared normal. Myelin and myelin-like fractions, isolated from diseased and normal brain tissue, were of a primitive developing nature but appeared to be comparable. The findings indicate a neonatal sudanophilic leukodystrophy which doubtless began in prenatal life and which was rich in cholesteryl ester. The aetiology of the leukodystrophy is unknown.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 978227     DOI: 10.1016/0022-510x(76)90258-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Infantile sudanophilic leukodystrophy: computed tomography demonstration.

Authors:  N Sano; H Nagao; T Morimoto; M Takahashi; S Habara; T Aoi; H Matsuda; S Kamoshita
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

2.  Postnatal sudanophilic leukodystrophy in two siblings.

Authors:  S Yokoi; N Amano; H Hanawa; K Isoyama; A Ishikawa; T Ogino
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.